European Journal of Clinical Pharmacology

, Volume 63, Issue 6, pp 565–570

Adverse effects by artificial grapefruit seed extract products in patients on warfarin therapy

  • Helena Brandin
  • Olle Myrberg
  • Torgny Rundlöf
  • Ann-Kristin Arvidsson
  • Gunilla Brenning
Pharmacokinetics and Disposition

DOI: 10.1007/s00228-007-0289-1

Cite this article as:
Brandin, H., Myrberg, O., Rundlöf, T. et al. Eur J Clin Pharmacol (2007) 63: 565. doi:10.1007/s00228-007-0289-1

Abstract

Objective

Grapefruit seed extract (GSE) is promoted as a natural product with antibacterial and antiviral properties. The aim of this study was to investigate the composition of some commercially available GSE products and evaluate their effect in vitro on two cytochrome P450 enzymes, CYP2C9 and CYP3A4.

Methods

A couple on lifelong treatment with warfarin and continuous regular follow-ups took some drops of a GSE product for 3 days. The female patient experienced a minor subcutaneous haematoma 3 days later, and her international normalised ratio (INR) value was 7.9. This was reported to the Swedish Medical Products Agency (MPA) as a spontaneous post-marketing report concerning adverse drug reactions/interactions. The composition of the GSE products was determined by proton and carbon-13 nuclear magnetic resonance spectroscopy (NMR). The inhibitory effect of the GSE products on the cytochrome P450 enzymes was tested in an in vitro baculosome assay.

Results

The NMR analysis showed that all three investigated GSE products contained the synthetic preservative benzethonium chloride (BTC) in addition to glycerol and water. No authentic GSE extract was found in any of the three GSE products analysed. Furthermore, BTC was found to be a potent inhibitor of CYP3A4 and CYP2C9 activity in vitro.

Conclusion

Our results suggest that BTC in the GSE products is responsible for the increase in the INR value in a patient on warfarin treatment.

Keywords

Grapefruit seed extract Benzethonium chloride Warfarin 

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Helena Brandin
    • 1
  • Olle Myrberg
    • 1
  • Torgny Rundlöf
    • 1
  • Ann-Kristin Arvidsson
    • 1
  • Gunilla Brenning
    • 2
  1. 1.Laboratory DepartmentMedical Products AgencyUppsalaSweden
  2. 2.Department of PharmacovigilanceMedical Products AgencyUppsalaSweden

Personalised recommendations